You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity

 

Online download statistics by month:

Online download statistics by month: April 2022 to June 2025

AbstractFullPdf
Apr 2022322326122
May 2022261269112
Jun 202216517847
Jul 202213413626
Aug 202215515830
Sep 202213513732
Oct 202214014346
Nov 202212212439
Dec 2022949422
Jan 2023989941
Feb 2023939426
Mar 2023686945
Apr 2023404121
May 2023484836
Jun 202328288
Jul 2023484928
Aug 2023888828
Sep 2023565618
Oct 2023535319
Nov 2023555525
Dec 2023353523
Jan 2024585926
Feb 2024414128
Mar 2024525279
Apr 2024656539
May 2024434520
Jun 2024616032
Jul 2024697136
Aug 2024353670
Sep 2024474792
Oct 2024474734
Nov 2024525333
Dec 2024929924
Jan 2025424218
Feb 202514914942
Mar 2025595948
Apr 2025767656
May 2025434338
Jun 2025404017
Total330933641526